CHThe article reports that the Swiss pharmaceutical company Lonza has expanded its partnership with a U.S.-based client. The announcement highlights increased collaboration between the two companies, likely involving production or research activities. While the details of the partnership are not specified, the expansion suggests a strengthening of their business relationship. The focus is on corporate development rather than any political or social controversy.
Lecture du biais (Centre): The article covers a business development without any political implications or controversial framing. It presents information about a corporate partnership without taking sides or introducing ideological perspectives.
